Concepedia

Linda Law

LL

Statistics

Publications

10

Citations

659

H-Index

10

Active since

1973

Affiliations

The University of Sydney(Current)

Dana-Farber Cancer Institute

George Institute for Global Health

Royal Prince Alfred Hospital

NIHR Leicester Cardiovascular Biomedical Research Unit

Linda Law is an author at The University of Sydney specializing in medicine, pharmacotherapy, and gastrointestinal oncology.

Publications per year

1973–2019

10

Publications

10

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Yining Huang, Richard I. Lindley, Xiaoying Chen et al. · The Lancet · 2019 · 271 citations · Full text

, , +13

Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide

Matthew H. Kulke, Thomas M. O’Dorisio, Alexandria T. Phan et al. · Endocrine Related Cancer · 2014 · 127 citations · Full text

, , +15

Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl

Lowell Anthony, Claire Ervin, Pablo Lapuerta et al. · Clinical Therapeutics · 2017 · 50 citations · Full text

, , +15

Microbiological diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis

Stephen I. Vas, Linda Law · Journal of Clinical Microbiology · 1985 · 47 citations · Full text

, , +10

Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach

Heather L. Gelhorn, Matthew H. Kulke, Thomas M. O’Dorisio et al. · Clinical Therapeutics · 2016 · 47 citations · Full text

, , +15

1–5 of 10